Compositions and methods for controlling nematodes
US-2019021325-A1 · Jan 24, 2019 · US
US10827753B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10827753-B2 |
| Application number | US-201916507535-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 10, 2019 |
| Priority date | Aug 13, 2007 |
| Publication date | Nov 10, 2020 |
| Grant date | Nov 10, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Compositions and methods for controlling nematodes are described herein, e.g., nematodes that infest plants or animals. The compounds include oxazoles, oxadiazoles and thiadiazoles.
Opening claim text (preview).
What is claimed is: 1. A nematicidal composition comprising: an effective amount of a compound of Formula IV, Formula V, or a salt thereof wherein, A is phenyl, pyrazyl, oxazolyl or isoxazolyl, each of which can be optionally independently substituted with one or more substituents selected from the group consisting of halogen, CF 3 , CH 3 , OCF 3 , OCH 3 , CN, and C(H)O; and C is thienyl, furanyl, oxazolyl or isoxazolyl, each of which can be optionally independently substituted with one or more substituents selected from the group consisting of fluorine, chlorine, CH 3 , and OCF 3 ; and one or more of an insecticide, a fungicide, a herbicide, or another pesticide selected from the group consisting of an avermectin, milbemycin, imidacloprid, aldicarb, oxamyl, fenamiphos, fosthiazate, metam sodium, etridiazole, penta-chloro-nitrobenzene (PCNB), flutolanil, metalaxyl, mefonoxam, fosetyl-al, silthiofam, fludioxonil, myclobutanil, azoxystrobin, chlorothalonil, propiconazole, tebuconazole, pyraclostrobin, trifloxysulfuron, glyphosate, and halosulfuron. 2. The composition of claim 1 wherein A is phenyl. 3. The composition of claim 1 wherein A is pyrazyl. 4. The composition of claim 1 wherein A is oxazolyl. 5. The composition of claim 1 wherein A is isoxazolyl. 6. The composition of claim 1 wherein C is thienyl. 7. The composition of claim 1 wherein C is furanyl. 8. The composition of claim 1 wherein C is oxazolyl. 9. The composition of claim 1 wherein C is isoxazolyl. 10. The composition of claim 1 comprising a compound of Formula IVa or a salt thereof, wherein R 1 and R 5 are independently selected from hydrogen, CH 3 , F, Cl, Br, CF 3 and OCF 3 ; R 2 and R 4 are independently selected from hydrogen, F, Cl, Br, and CF 3 ; R 3 is selected from hydrogen, CH 3 , CF 3 , F, Cl, Br, OCF 3 , OCH 3 , CN, and C(H)O; R 7 and R 8 are independently selected from hydrogen and fluorine; R 9 is selected from hydrogen, F, Cl, CH 3 , and OCF 3 ; and E is O or S. 11. The composition of claim 1 comprising a compound of Formula IVb or a salt thereof, wherein R 1 and R 5 are independently selected from hydrogen, CH 3 , F, Cl, Br, CF 3 and OCF 3 ; R 2 and R 4 are independently selected from hydrogen, F, Cl, Br, and CF 3 ; R 3 is selected from hydrogen, CH 3 , CF 3 , F, Cl, Br, OCF 3 , OCH 3 , CN, and C(H)O; R 8 is selected from hydrogen and fluorine; R 6 and R 9 are independently selected from hydrogen, F, Cl, CH 3 , and OCF 3 ; and E is O or S. 12. The composition of claim 1 comprising a compound of Formula Va or a salt thereof, wherein, R 1 and R 5 are independently selected from hydrogen, CH 3 , F, Cl, Br, CF 3 and OCF 3 ; R 2 and R 4 are independently selected from hydrogen, F, Cl, Br, and CF 3 ; R 3 is selected from hydrogen, CH 3 , CF 3 , F, Cl, Br, OCF 3 , OCH 3 , CN, and C(H)O; R 7 and R 8 are independently selected from hydrogen and fluorine; R 9 is selected from hydrogen, F, Cl, CH 3 , and OCF 3 ; and E is O or S. 13. The composition of claim 1 comprising a compound of Formula Vb or a salt thereof, wherein R 1 and R 5 are independently selected from hydrogen, CH 3 , F, Cl, Br, CF 3 and OCF 3 ; R 2 and R 4 are independently selected from hydrogen, F, Cl, Br, and CF 3 ; R 3 is selected from hydrogen, CH 3 , CF 3 , F, Cl, Br, OCF 3 , OCH 3 , CN, and C(H)O; R 8 is selected from hydrogen and fluorine; R 6 and R 9 are independently selected from hydrogen, F, Cl, CH 3 , and OCF 3 ; and E is O or S. 14. The composition of claim 10 wherein E is O. 15. The composition of claim 10 wherein E is S. 16. The composition of claim 1 comprising a compound selected from the group consisting of: 3-phenyl-5-(thiophen-2-yl)-1,2,4-oxadiazole, 5-(furan-2-yl)-3-phenyl-1,2,4-oxadiazole, 3-(4-fluorophenyl)-5-(thiophen-2-yl)-1,2,4-oxadiazole, 3-(4-fluorophenyl)-5-(furan-2-yl)-1,2,4-oxadiazole, 3-(4-chlorophenyl)-5-(thiophen-2-yl)-1,2,4-oxadiazole, 3-(4-chlorophenyl)-5-(furan-2-yl)-1,2,4-oxadiazole, 3-(4-bromophenyl)-5-(thiophen-2-yl)-1,2,4-oxadiazole, 3-(4-bromophenyl)-5-(furan-2-yl)-1,2,4-oxadiazole, 3-(4-chloro-2-methylphenyl)-5-(furan-2-yl)-1,2,4-oxadiazole, 3-(2,4-dichlorophenyl)-5-(furan-2-yl)-1,2,4-oxadiazole, 3-(4-chlorophenyl)-5-(thiophen-3-yl)-1,2,4-oxadiazole, 3-(4-chlorophenyl)-5-(furan-3-yl)-1,2,4-oxadiazole, 3-(4-fluorophenyl)-5-(thiophen-3-yl)-1,2,4-oxadiazole, and 3-(4-fluorophenyl)-5-(furan-3-yl)-1,2,4-oxadiazole. 17. The composition of claim 16 comprising 3-phenyl-5-(thiophen-2-yl)-1,2,4-oxadiazole. 18. The composition of claim 1 further comprising water. 19. The composition of claim 1 in the form of a concentrate. 20. The composition of claim 1 further comprising a solvent in which the compound of Formula IV, Formula V, or a salt thereof is dissolved. 21. The composition of claim 20 further comprising a co-solvent. 22. The composition of claim 21 wherein the co-solvent is selected from the group consisting of ethyl lactate, methyl soyate, isopropanol, acetone, 1,2-propanediol, n-alkylpyrrolidone, petroleum-based oil and mineral oil. 23. The composition of claim 1 further comprising an aqueous surfactant. 24. The composition of claim 1 further comprising a permeation enhancer. 25. The composition of claim 16 comprising 5-(furan-2-yl)-3-phenyl-1,2,4-oxadiazole.
1,3-Oxazoles; Hydrogenated 1,3-oxazoles · CPC title
directly linked by a ring-member-to-ring-member bond · CPC title
containing a —O—CO—N< group, or a thio analogue thereof, neither directly attached to a ring nor the nitrogen atom being a member of a heterocyclic ring · CPC title
containing three or more hetero rings · CPC title
directly linked by a ring-member-to-ring-member bond · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.